Execs On The Move, April 2022 Roundup: Shake Ups At Glaukos, Medtronic, BD And Globus
Executive Summary
Executives On The Move will be running to a monthly schedule from now, with this edition covering medtech's executive changes for April.
You may also be interested in...
Globus Medical Completes First Surgery With Excelsius Imaging System
Globus Medical CFO Keith Pfeil said “enthusiasm is great” with “more than double-digit orders” for the Excelsius3D system.
Meet Embecta! Becton Dickinson Completes Diabetes Spin-Off
Becton Dickinson has formally completed the planned spin-off of its diabetes business within the timeframe it projected about a year ago. The new company, called embecta, is one of the largest producers of diabetes injection devices.
Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.